Cargando…
Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776396/ https://www.ncbi.nlm.nih.gov/pubmed/26941012 http://dx.doi.org/10.1186/s12974-016-0507-9 |
_version_ | 1782419147069587456 |
---|---|
author | Liba, Zuzana Kayserova, Jana Elisak, Martin Marusic, Petr Nohejlova, Hana Hanzalova, Jitka Komarek, Vladimir Sediva, Anna |
author_facet | Liba, Zuzana Kayserova, Jana Elisak, Martin Marusic, Petr Nohejlova, Hana Hanzalova, Jitka Komarek, Vladimir Sediva, Anna |
author_sort | Liba, Zuzana |
collection | PubMed |
description | BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance. There are limited data regarding T cell involvement in the disease. To contribute to the current knowledge, we investigated the complex system of chemokines and cytokines related to B and T cell functions in CSF and sera samples from anti-NMDAR encephalitis patients at different time-points of the disease. One patient in our study group had a long-persisting coma and underwent extraordinary immunosuppressive therapy. METHODS: Twenty-seven paired CSF/serum samples were collected from nine patients during the follow-up period (median 12 months, range 1–26 months). The patient samples were stratified into three periods after the onset of the first disease symptom and compared with the controls. Modified Rankin score (mRS) defined the clinical status. The concentrations of the chemokines (C-X-C motif ligand (CXCL)10, CXCL8 and C-C motif ligand 2 (CCL2)) and the cytokines (interferon (IFN)γ, interleukin (IL)4, IL7, IL15, IL17A and tumour necrosis factor (TNF)α) were measured with Luminex multiple bead technology. The B cell-activating factor (BAFF) and CXCL13 concentrations were determined via enzyme-linked immunosorbent assay. We correlated the disease period with the mRS, pleocytosis and the levels of all of the investigated chemokines and cytokines. Non-parametric tests were used, a P value <0.05 was considered to be significant. RESULTS: The increased CXCL10 and CXCL13 CSF levels accompanied early-stage disease progression and pleocytosis. The CSF CXCL10 and CXCL13 levels were the highest in the most complicated patient. The CSF BAFF levels remained unchanged through the periods. In contrast, the CSF levels of T cell-related cytokines (INFγ, TNFα and IL17A) and IL15 were slightly increased at all of the periods examined. No dynamic changes in chemokine and cytokine levels were observed in the peripheral blood. CONCLUSIONS: Our data support the hypothesis that anti-NMDAR encephalitis is restricted to the CNS and that chemoattraction of immune cells dominates at its early stage. Furthermore, our findings raise the question of whether T cells are involved in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0507-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4776396 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47763962016-03-04 Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid Liba, Zuzana Kayserova, Jana Elisak, Martin Marusic, Petr Nohejlova, Hana Hanzalova, Jitka Komarek, Vladimir Sediva, Anna J Neuroinflammation Research BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance. There are limited data regarding T cell involvement in the disease. To contribute to the current knowledge, we investigated the complex system of chemokines and cytokines related to B and T cell functions in CSF and sera samples from anti-NMDAR encephalitis patients at different time-points of the disease. One patient in our study group had a long-persisting coma and underwent extraordinary immunosuppressive therapy. METHODS: Twenty-seven paired CSF/serum samples were collected from nine patients during the follow-up period (median 12 months, range 1–26 months). The patient samples were stratified into three periods after the onset of the first disease symptom and compared with the controls. Modified Rankin score (mRS) defined the clinical status. The concentrations of the chemokines (C-X-C motif ligand (CXCL)10, CXCL8 and C-C motif ligand 2 (CCL2)) and the cytokines (interferon (IFN)γ, interleukin (IL)4, IL7, IL15, IL17A and tumour necrosis factor (TNF)α) were measured with Luminex multiple bead technology. The B cell-activating factor (BAFF) and CXCL13 concentrations were determined via enzyme-linked immunosorbent assay. We correlated the disease period with the mRS, pleocytosis and the levels of all of the investigated chemokines and cytokines. Non-parametric tests were used, a P value <0.05 was considered to be significant. RESULTS: The increased CXCL10 and CXCL13 CSF levels accompanied early-stage disease progression and pleocytosis. The CSF CXCL10 and CXCL13 levels were the highest in the most complicated patient. The CSF BAFF levels remained unchanged through the periods. In contrast, the CSF levels of T cell-related cytokines (INFγ, TNFα and IL17A) and IL15 were slightly increased at all of the periods examined. No dynamic changes in chemokine and cytokine levels were observed in the peripheral blood. CONCLUSIONS: Our data support the hypothesis that anti-NMDAR encephalitis is restricted to the CNS and that chemoattraction of immune cells dominates at its early stage. Furthermore, our findings raise the question of whether T cells are involved in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0507-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-03 /pmc/articles/PMC4776396/ /pubmed/26941012 http://dx.doi.org/10.1186/s12974-016-0507-9 Text en © Liba et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Liba, Zuzana Kayserova, Jana Elisak, Martin Marusic, Petr Nohejlova, Hana Hanzalova, Jitka Komarek, Vladimir Sediva, Anna Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title_full | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title_fullStr | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title_full_unstemmed | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title_short | Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
title_sort | anti-n-methyl-d-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776396/ https://www.ncbi.nlm.nih.gov/pubmed/26941012 http://dx.doi.org/10.1186/s12974-016-0507-9 |
work_keys_str_mv | AT libazuzana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT kayserovajana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT elisakmartin antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT marusicpetr antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT nohejlovahana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT hanzalovajitka antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT komarekvladimir antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid AT sedivaanna antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid |